Jeantet advises Intrasense in the context of the voluntary tender offer for its shares launched by its reference shareholder Guerbet
Paris, June 16, 2023, Jeantet advised Intrasense, a company specializing in medical imaging software solutions listed on Euronext Growth Paris, in the context of the voluntary tender offer (the “Offer”) for its shares, launched by its reference shareholder Guerbet, following the share capital increase reserved to Guerbet for a total amount of €8.8 million, dated January 11, 2023.
At the opening of the Offer, Guerbet held 25,049,230 Intrasense shares, representing 48.34% of the share capital and 48.03% of the voting rights of Intrasense.
The Offer, declared compliant by the French Financial Markets Authority (“AMF”) on April 4, 2023 and opened from April 6 to May 15, 2023 and then reopened from May 23 to June 5, 2023, offered Intrasense shareholders a price of €0.44 per share, in order to offer them an immediate liquidity under the same price conditions as the share capital increase previously reserved to Guerbet.
As a result of the Offer, Guerbet holds 29,257,966 Intrasense shares, representing 56.46% of the share capital and at least 56.10% of the voting rights of Intrasense.
The settlement and delivery of the reopened Offer occurred on June 14, 2023.